Drug Safety Board Will Lead To More Advisory Cmte. Meetings – FDA’s Galson

The advent of FDA's Drug Safety Oversight Board will likely lead to an increase in the number of advisory committee meetings, Center for Drug Evaluation & Research Acting Director Steven Galson said at a meeting of FDA's Science Board April 15